Meyka Pro banner
Opthea Limited

Opthea Limited (OPT) Stock Overview

Explore Opthea Limited’s financial performance, market position, analyst ratings, and future outlook.

OPTNASDAQ
HealthcareBiotechnology
$3.41
$0.05(1.49%)
U.S. Market is Open · 15:10

Opthea Limited (OPT)

Meyka AI Score

Z

Key Financials

Market Cap4.2B
P/E Ratio-3.28
EPS (TTM)$-2.25
ROE1.18%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$6.14

OPT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Opthea Limited (NASDAQ: OPT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Opthea Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of OPT on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $6.14 for the NASDAQ listing.

Key metrics behind Opthea Limited's NASDAQ-traded stock include a P/E ratio of -3.28 and a market capitalization of 4.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of OPT on the NASDAQ.

Price Performance (NASDAQ: OPT)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-38.67%
6-Month Change
-21.43%
Year-to-Date (YTD) Change
-7.59%
1-Year Change
3.65%
3-Year Change
-41.81%
5-Year Change
-72.28%
All-Time (Max) Change
-72.28%

Contact Information

61 3 9826 0399
650 Chapel Street, South Yarra, VIC, 3141

Company Facts

330 Employees
IPO DateOct 16, 2020
CountryAU

Frequently Asked Questions